Human papilloma virus in oral cancer

Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical malignancies, infection with some types of human papilloma virus (HPV) is well known to be the greatest cervical cancer risk factor. Over 150...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Korean Association of Oral and Maxillofacial Surgeons Vol. 42; no. 6; pp. 327 - 336
Main Author Kim, Soung Min
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Association of Oral and Maxillofacial Surgeons 01.12.2016
대한구강악안면외과학회
Subjects
Review
치의학
Human papilloma virus
Virus-like particle
Oral cancer
HPV vaccine
Uterine cervical cancer
Online AccessGet full text

Cover

Abstract Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical malignancies, infection with some types of human papilloma virus (HPV) is well known to be the greatest cervical cancer risk factor. Over 150 subtypes of HPV have been identified; more than 40 types of HPVs are typically transmitted through sexual contact and infect the anogenital region and oral cavity. The recently introduced vaccine for HPV infection is effective against certain subtypes of HPV that are associated with cervical cancer, genital warts, and some less common cancers, including oropharyngeal cancer. Two HPV vaccines, quadrivalent and bivalent types that use virus-like particles (VLPs), are currently used in the medical commercial market. While the value of HPV vaccination for oral cancer prevention is still controversial, some evidence supports the possibility that HPV vaccination may be effective in reducing the incidence of oral cancer. This paper reviews HPV-related pathogenesis in cancer, covering HPV structure and classification, trends in worldwide applications of HPV vaccines, effectiveness and complications of HPV vaccination, and the relationship of HPV with oral cancer prevalence.
AbstractList Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical malignancies, infection with some types of human papilloma virus (HPV) is well known to be the greatest cervical cancer risk factor. Over 150 subtypes of HPV have been identified; more than 40 types of HPVs are typically transmitted through sexual contact and infect the anogenital region and oral cavity. The recently introduced vaccine for HPV infection is effective against certain subtypes of HPV that are associated with cervical cancer, genital warts, and some less common cancers, including oropharyngeal cancer. Two HPV vaccines, quadrivalent and bivalent types that use virus-like particles (VLPs), are currently used in the medical commercial market. While the value of HPV vaccination for oral cancer prevention is still controversial, some evidence supports the possibility that HPV vaccination may be effective in reducing the incidence of oral cancer. This paper reviews HPV-related pathogenesis in cancer, covering HPV structure and classification, trends in worldwide applications of HPV vaccines, effectiveness and complications of HPV vaccination, and the relationship of HPV with oral cancer prevalence.Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical malignancies, infection with some types of human papilloma virus (HPV) is well known to be the greatest cervical cancer risk factor. Over 150 subtypes of HPV have been identified; more than 40 types of HPVs are typically transmitted through sexual contact and infect the anogenital region and oral cavity. The recently introduced vaccine for HPV infection is effective against certain subtypes of HPV that are associated with cervical cancer, genital warts, and some less common cancers, including oropharyngeal cancer. Two HPV vaccines, quadrivalent and bivalent types that use virus-like particles (VLPs), are currently used in the medical commercial market. While the value of HPV vaccination for oral cancer prevention is still controversial, some evidence supports the possibility that HPV vaccination may be effective in reducing the incidence of oral cancer. This paper reviews HPV-related pathogenesis in cancer, covering HPV structure and classification, trends in worldwide applications of HPV vaccines, effectiveness and complications of HPV vaccination, and the relationship of HPV with oral cancer prevalence.
Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical malignancies, infection with some types of human papilloma virus (HPV) is well known to be the greatest cervical cancer risk factor. Over 150 subtypes of HPV have been identified; more than 40 types of HPVs are typically transmitted through sexual contact and infect the anogenital region and oral cavity. The recently introduced vaccine for HPV infection is effective against certain subtypes of HPV that are associated with cervical cancer, genital warts, and some less common cancers, including oropharyngeal cancer. Two HPV vaccines, quadrivalent and bivalent types that use virus-like particles (VLPs), are currently used in the medical commercial market. While the value of HPV vaccination for oral cancer prevention is still controversial, some evidence supports the possibility that HPV vaccination may be effective in reducing the incidence of oral cancer. This paper reviews HPV-related pathogenesis in cancer, covering HPV structure and classification, trends in worldwide applications of HPV vaccines, effectiveness and complications of HPV vaccination, and the relationship of HPV with oral cancer prevalence.
Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical malignancies, infection with some types of human papilloma virus (HPV) is well known to be the greatest cervical cancer risk factor. Over 150 subtypes of HPV have been identified; more than 40 types of HPVs are typically transmitted through sexual contact and infect the anogenital region and oral cavity. The recently introduced vaccine for HPV infection is effective against certain subtypes of HPV that are associated with cervical cancer, genital warts, and some less common cancers, including oropharyngeal cancer. Two HPV vaccines, quadrivalent and bivalent types that use virus-like particles (VLPs), are currently used in the medical commercial market. While the value of HPV vaccination for oral cancer prevention is still contro-versial, some evidence supports the possibility that HPV vaccination may be effective in reducing the incidence of oral cancer. This paper reviews HPV-related pathogenesis in cancer, covering HPV structure and classification, trends in worldwide applications of HPV vaccines, effectiveness and complications of HPV vaccination, and the relationship of HPV with oral cancer prevalence. KCI Citation Count: 1
Author Kim, Soung Min
AuthorAffiliation 2 Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
1 Oral and Maxillofacial Microvascular Reconstruction Lab, Brong Ahafo Regional Hospital, Sunyani, Ghana
AuthorAffiliation_xml – name: 2 Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
– name: 1 Oral and Maxillofacial Microvascular Reconstruction Lab, Brong Ahafo Regional Hospital, Sunyani, Ghana
Author_xml – sequence: 1
  givenname: Soung Min
  orcidid: 0000-0002-6916-0489
  surname: Kim
  fullname: Kim, Soung Min
  organization: Oral and Maxillofacial Microvascular Reconstruction Lab, Brong Ahafo Regional Hospital, Sunyani, Ghana., Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28053902$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002175093$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kUtLxDAUhYMovv-BSBcudDE1jyZpXQgivkAQRNeXNE01TpuMSSv47804o6gLs7mBnPPdm3u20KrzziC0R3DOCeXHL1Pl-5hTTERe0FzkjMoVtEkpKya8Ynh1eZec4w20G-MLTkdQySRdRxu0xJxVmG6ig-uxVy6bqZntOt-r7M2GMWbWZT6oLtPKaRN20Fqrumh2l3UbPV5ePJxfT27vrm7Oz24nOmGHiSmFaQRhwpRNVctWt1RiVdVa1qQVpW4qytqKiEI2rCk0M7LUWFZEl1rUvGjZNjpacF1oYaoteGU_65OHaYCz-4cbIDR9r2RJe7rQzsa6N402bkgDwyzYXoX3T-fvF2efE-cNOE17YDIBDpeA4F9HEwfobdSm65QzfoxASs5lhSUnSbr_s9d3k681JsHJQqCDjzGYFrQd1GD9vLXtgGCYxwaL2GAeGxQUBKTYkrn4Y_7i_2v7ADjLnKU
CitedBy_id crossref_primary_10_1007_s00405_020_06405_w
crossref_primary_10_15406_jhvrv_2020_08_00232
crossref_primary_10_4103_IJPM_IJPM_511_20
crossref_primary_10_1038_s41415_020_2113_6
crossref_primary_10_14777_uti_2023_18_1_20
crossref_primary_10_1002_osi2_1022
crossref_primary_10_1016_j_nano_2023_102662
crossref_primary_10_2478_amma_2023_0005
crossref_primary_10_4103_jpbs_jpbs_607_22
crossref_primary_10_3389_fonc_2021_614448
crossref_primary_10_1016_j_currproblcancer_2024_101100
crossref_primary_10_1097_MD_0000000000012846
crossref_primary_10_1007_s00405_017_4828_9
crossref_primary_10_1002_osi2_1226
crossref_primary_10_1007_s00405_017_4662_0
crossref_primary_10_1016_j_trac_2024_117979
crossref_primary_10_1016_j_oor_2024_100264
crossref_primary_10_1158_1055_9965_EPI_21_1056
crossref_primary_10_5005_jp_journals_10024_3240
crossref_primary_10_5005_jp_journals_10024_3483
crossref_primary_10_3390_membranes11060453
crossref_primary_10_5005_jp_journals_10024_2791
crossref_primary_10_1016_j_clinsp_2024_100477
crossref_primary_10_4103_jdmimsu_jdmimsu_815_23
crossref_primary_10_36740_WLek202206105
crossref_primary_10_1007_s11033_020_05927_0
crossref_primary_10_1039_D3OB01252B
crossref_primary_10_1155_2018_6086595
crossref_primary_10_1016_j_procbio_2022_04_013
crossref_primary_10_1186_s12957_024_03492_5
crossref_primary_10_18632_oncotarget_16207
crossref_primary_10_3390_ijms241914593
crossref_primary_10_1111_jop_12770
crossref_primary_10_33808_clinexphealthsci_731725
crossref_primary_10_1007_s12672_025_01998_2
crossref_primary_10_4103_jfmpc_jfmpc_1669_20
crossref_primary_10_3389_fmicb_2018_02450
crossref_primary_10_1016_j_ajoms_2025_02_008
crossref_primary_10_2217_fvl_2017_0053
crossref_primary_10_3892_or_2023_8650
crossref_primary_10_5124_jkma_2017_60_3_257
crossref_primary_10_4103_jcrt_JCRT_957_19
crossref_primary_10_1002_jmv_24953
crossref_primary_10_1007_s12105_021_01309_5
crossref_primary_10_3390_v16121893
crossref_primary_10_4103_jofs_jofs_258_21
crossref_primary_10_3390_toxics8030073
crossref_primary_10_1186_s12985_024_02496_7
crossref_primary_10_3892_or_2017_5953
crossref_primary_10_2478_s11756_019_00386_w
crossref_primary_10_1111_jop_12800
crossref_primary_10_1371_journal_pone_0269655
crossref_primary_10_3103_S0891416823040122
crossref_primary_10_1186_s13027_020_00287_7
crossref_primary_10_1002_osi2_1277
crossref_primary_10_1002_ppsc_202100115
crossref_primary_10_1155_2024_9725822
crossref_primary_10_1177_11795549221084832
crossref_primary_10_1590_1807_3107bor_2019_vol33_0091
crossref_primary_10_1016_j_oraloncology_2018_07_018
crossref_primary_10_1016_j_bbadis_2022_166517
crossref_primary_10_1111_omi_12412
crossref_primary_10_54097_hset_v19i_2845
crossref_primary_10_1016_j_talanta_2023_125495
crossref_primary_10_1080_15376516_2019_1646372
crossref_primary_10_3390_pathogens12010025
crossref_primary_10_1016_j_ajoms_2024_02_008
Cites_doi 10.1016/j.virol.2008.11.046
10.1097/00004347-200001000-00004
10.1586/14760584.6.5.723
10.1136/jcp.43.4.269
10.1186/1746-160X-6-15
10.5125/jkaoms.2012.38.1.20
10.1093/jnci/djn025
10.1056/NEJMoa021641
10.1038/sj.clpt.6100055
10.1016/0042-6822(91)90772-4
10.1128/JVI.02726-07
10.1136/jcp.55.4.244
10.1007/s00705-009-0484-8
10.1158/1055-9965.EPI-04-0551
10.4047/jap.2014.6.6.555
10.1016/j.virol.2004.03.033
10.1016/j.vaccine.2015.08.059
10.4161/hv.20043
10.1111/j.1600-0714.2007.00579.x
10.1016/j.jadohealth.2011.07.003
10.1046/j.1365-4362.1998.00435.x
10.1097/PAS.0000000000000342
10.3233/JRS-2011-0529
10.7883/yoken.64.34
10.7774/cevr.2014.3.2.168
10.1016/j.ijom.2008.05.015
10.4161/hv.7.3.14263
10.1002/j.1460-2075.1989.tb08594.x
10.1016/j.vaccine.2012.05.039
10.1016/j.ebiom.2015.07.003
10.4103/0973-1482.82915
10.1097/PAP.0b013e3181f895c1
10.1001/jama.2009.1201
10.1016/j.arcmed.2009.06.001
10.1128/MMBR.00033-08
10.1067/moe.2001.115128
10.1038/modpathol.3880113
10.1016/S0006-3495(91)82181-6
10.1126/science.2157286
10.1186/1758-3284-2-15
10.1111/j.1834-7819.2011.01337.x
10.1097/INF.0000000000000793
10.1017/S0950268815002198
10.1056/NEJMoa1010971
10.3390/jcm4040614
10.1097/CCO.0000000000000211
10.1111/j.1471-0528.1988.tb06785.x
10.1007/s12105-012-0367-2
10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
10.1038/nrc798
10.1093/ije/dyp350
10.1093/jnci/djn011
10.1111/j.1600-0463.2010.02624.x
10.1067/moe.2001.115392
10.1016/0266-4356(91)90006-Q
10.1136/jcp.2008.063149
10.1016/j.oraloncology.2012.01.017
10.1038/nrc2982
10.1016/0007-117X(83)90060-4
10.1016/S1368-8375(01)00112-9
10.1093/jnci/djj144
ContentType Journal Article
Copyright Copyright © 2016 The Korean Association of Oral and Maxillofacial Surgeons. All rights reserved. 2016
Copyright_xml – notice: Copyright © 2016 The Korean Association of Oral and Maxillofacial Surgeons. All rights reserved. 2016
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.5125/jkaoms.2016.42.6.327
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2234-5930
EndPage 336
ExternalDocumentID oai_kci_go_kr_ARTI_1293083
PMC5206237
28053902
10_5125_jkaoms_2016_42_6_327
Genre Journal Article
Review
GrantInformation_xml – fundername: ;
  grantid: NRF-2015K1A3A9A01028230
GroupedDBID 5-W
8JR
8XY
9ZL
AAYXX
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
CITATION
EF.
HYE
KQ8
KVFHK
M48
OK1
PGMZT
RPM
NPM
7X8
5PM
.UV
ACYCR
ID FETCH-LOGICAL-c372t-e86ed6136e8d9b7fcf270a9bc7b1f68cd923f91647d3d4c3e78c0791c8c6b54f3
IEDL.DBID M48
ISSN 2234-7550
IngestDate Tue Nov 21 21:31:23 EST 2023
Thu Aug 21 18:11:13 EDT 2025
Fri Jul 11 02:33:21 EDT 2025
Thu Apr 03 07:06:48 EDT 2025
Tue Jul 01 02:03:27 EDT 2025
Thu Apr 24 23:03:01 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human papilloma virus
Virus-like particle
Oral cancer
HPV vaccine
Uterine cervical cancer
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-e86ed6136e8d9b7fcf270a9bc7b1f68cd923f91647d3d4c3e78c0791c8c6b54f3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
G704-000546.2016.42.6.013
ORCID 0000-0002-6916-0489
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.5125/jkaoms.2016.42.6.327
PMID 28053902
PQID 1855790751
PQPubID 23479
PageCount 10
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1293083
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5206237
proquest_miscellaneous_1855790751
pubmed_primary_28053902
crossref_citationtrail_10_5125_jkaoms_2016_42_6_327
crossref_primary_10_5125_jkaoms_2016_42_6_327
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-12-01
PublicationDateYYYYMMDD 2016-12-01
PublicationDate_xml – month: 12
  year: 2016
  text: 2016-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of the Korean Association of Oral and Maxillofacial Surgeons
PublicationTitleAlternate J Korean Assoc Oral Maxillofac Surg
PublicationYear 2016
Publisher The Korean Association of Oral and Maxillofacial Surgeons
대한구강악안면외과학회
Publisher_xml – name: The Korean Association of Oral and Maxillofacial Surgeons
– name: 대한구강악안면외과학회
References Rybicki (10.5125/jkaoms.2016.42.6.327_ref70) 2011; 7
Feller (10.5125/jkaoms.2016.42.6.327_ref43) 2010; 6
Huygen (10.5125/jkaoms.2016.42.6.327_ref56) 2015; 2
Villa (10.5125/jkaoms.2016.42.6.327_ref40) 2011; 56
Brotherton (10.5125/jkaoms.2016.42.6.327_ref67) 2015; 27
Lajer (10.5125/jkaoms.2016.42.6.327_ref37) 2010; 118
Santoro (10.5125/jkaoms.2016.42.6.327_ref25) 1997; 46
Lizano (10.5125/jkaoms.2016.42.6.327_ref11) 2009; 40
Kojima (10.5125/jkaoms.2016.42.6.327_ref32) 2002; 38
Labadie (10.5125/jkaoms.2016.42.6.327_ref66) 2011; 23
Syrjänen (10.5125/jkaoms.2016.42.6.327_ref21) 1988; 95
Leemans (10.5125/jkaoms.2016.42.6.327_ref42) 2011; 11
Ramqvist (10.5125/jkaoms.2016.42.6.327_ref75) 2011; 31
Arya (10.5125/jkaoms.2016.42.6.327_ref74) 2012; 8
Castle (10.5125/jkaoms.2016.42.6.327_ref45) 2016; 144
Kumaraswamy (10.5125/jkaoms.2016.42.6.327_ref50) 2011; 7
Garçon (10.5125/jkaoms.2016.42.6.327_ref57) 2007; 6
Cardoso (10.5125/jkaoms.2016.42.6.327_ref12) 2011; 20
Werness (10.5125/jkaoms.2016.42.6.327_ref24) 1990; 248
Snow (10.5125/jkaoms.2016.42.6.327_ref34) 2010; 17
Park (10.5125/jkaoms.2016.42.6.327_ref27) 2014; 6
Haupt (10.5125/jkaoms.2016.42.6.327_ref60) 2011; 49
van der Marel (10.5125/jkaoms.2016.42.6.327_ref4) 2015; 39
Miller (10.5125/jkaoms.2016.42.6.327_ref20) 2001; 91
Bouda (10.5125/jkaoms.2016.42.6.327_ref31) 2000; 13
Rautava (10.5125/jkaoms.2016.42.6.327_ref10) 2012; 6
Tindle (10.5125/jkaoms.2016.42.6.327_ref73) 1994; 186
Pfister (10.5125/jkaoms.2016.42.6.327_ref22) 1992; 3
Kash (10.5125/jkaoms.2016.42.6.327_ref58) 2015; 4
Chang (10.5125/jkaoms.2016.42.6.327_ref72) 1990; 43
Brisson (10.5125/jkaoms.2016.42.6.327_ref68) 2015
Fakhry (10.5125/jkaoms.2016.42.6.327_ref29) 2008; 100
Lazarczyk (10.5125/jkaoms.2016.42.6.327_ref14) 2009; 73
Majewski (10.5125/jkaoms.2016.42.6.327_ref71) 1998; 37
Matsushita (10.5125/jkaoms.2016.42.6.327_ref76) 2011; 64
Bosch (10.5125/jkaoms.2016.42.6.327_ref5) 2002; 55
McNeil (10.5125/jkaoms.2016.42.6.327_ref61) 2006; 98
Napier (10.5125/jkaoms.2016.42.6.327_ref39) 2008; 37
10.5125/jkaoms.2016.42.6.327_ref54
Vichnin (10.5125/jkaoms.2016.42.6.327_ref63) 2015; 34
10.5125/jkaoms.2016.42.6.327_ref53
Gillison (10.5125/jkaoms.2016.42.6.327_ref35) 2008; 100
10.5125/jkaoms.2016.42.6.327_ref59
zur Hausen (10.5125/jkaoms.2016.42.6.327_ref46) 1975
zur Hausen (10.5125/jkaoms.2016.42.6.327_ref49) 2009; 384
Cox (10.5125/jkaoms.2016.42.6.327_ref52) 1991; 29
de Villiers (10.5125/jkaoms.2016.42.6.327_ref7) 2004; 324
Buck (10.5125/jkaoms.2016.42.6.327_ref8) 2008; 82
Palefsky (10.5125/jkaoms.2016.42.6.327_ref55) 2011; 365
Femiano (10.5125/jkaoms.2016.42.6.327_ref19) 2000; 49
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (10.5125/jkaoms.2016.42.6.327_ref28) 2012
Greer (10.5125/jkaoms.2016.42.6.327_ref41) 2008; 37
Shi (10.5125/jkaoms.2016.42.6.327_ref62) 2007; 81
Münger (10.5125/jkaoms.2016.42.6.327_ref23) 1989; 8
Fornatora (10.5125/jkaoms.2016.42.6.327_ref26) 2001; 91
Bazan (10.5125/jkaoms.2016.42.6.327_ref69) 2009; 154
Zil-A-Rubab (10.5125/jkaoms.2016.42.6.327_ref77) 2013; 63
Baker (10.5125/jkaoms.2016.42.6.327_ref48) 1991; 60
Miralles-Guri (10.5125/jkaoms.2016.42.6.327_ref17) 2009; 62
Orth (10.5125/jkaoms.2016.42.6.327_ref13) 2008; 321
Mishra (10.5125/jkaoms.2016.42.6.327_ref38) 2012; 48
Slade (10.5125/jkaoms.2016.42.6.327_ref64) 2009; 302
Syrjänen (10.5125/jkaoms.2016.42.6.327_ref51) 1983; 21
Kim (10.5125/jkaoms.2016.42.6.327_ref33) 2014; 3
Campisi (10.5125/jkaoms.2016.42.6.327_ref18) 2007; 30
Sun (10.5125/jkaoms.2016.42.6.327_ref1) 2012; 38
Stoler (10.5125/jkaoms.2016.42.6.327_ref15) 2000; 19
zur Hausen (10.5125/jkaoms.2016.42.6.327_ref9) 2002; 2
Kreimer (10.5125/jkaoms.2016.42.6.327_ref16) 2005; 14
Markowitz (10.5125/jkaoms.2016.42.6.327_ref44) 2012; 30
Dayyani (10.5125/jkaoms.2016.42.6.327_ref30) 2010; 2
Zhou (10.5125/jkaoms.2016.42.6.327_ref47) 1991; 185
Heck (10.5125/jkaoms.2016.42.6.327_ref36) 2010; 39
Garland (10.5125/jkaoms.2016.42.6.327_ref65) 2015; 33
Forman (10.5125/jkaoms.2016.42.6.327_ref2) 2014
Muñoz (10.5125/jkaoms.2016.42.6.327_ref6) 2003; 348
Walboomers (10.5125/jkaoms.2016.42.6.327_ref3) 1999; 189
12571259 - N Engl J Med. 2003 Feb 6;348(6):518-27
21358269 - Hum Vaccin. 2011 Mar;7(3):339-48
11402272 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):622-35
18727487 - Curr Top Microbiol Immunol. 2008;321:59-83
11040544 - Minerva Stomatol. 2000 Apr;49(4):179-86
21884139 - Aust Dent J. 2011 Sep;56(3):253-6
18334711 - J Natl Cancer Inst. 2008 Mar 19;100(6):407-20
25558348 - J Adv Prosthodont. 2014 Dec;6(6):555-8
22782219 - Head Neck Pathol. 2012 Jul;6 Suppl 1:S3-15
21160525 - Nat Rev Cancer. 2011 Jan;11(1):9-22
2556261 - EMBO J. 1989 Dec 20;8(13):4099-105
20966645 - Adv Anat Pathol. 2010 Nov;17(6):394-403
8205843 - Curr Top Microbiol Immunol. 1994;186:217-53
19706632 - J Clin Pathol. 2009 Oct;62(10):870-8
22029979 - N Engl J Med. 2011 Oct 27;365(17):1576-85
19487731 - Microbiol Mol Biol Rev. 2009 Jun;73(2):348-70
19690307 - JAMA. 2009 Aug 19;302(7):750-7
16595773 - J Natl Cancer Inst. 2006 Apr 5;98(7):433
6307342 - Br J Oral Surg. 1983 Jun;21(2):147-53
20587061 - Head Neck Oncol. 2010 Jun 29;2:15
17931153 - Expert Rev Vaccines. 2007 Oct;6(5):723-39
20633288 - Head Face Med. 2010 Jul 15;6:15
23199957 - Vaccine. 2012 Nov 20;30 Suppl 5:F139-48
2849985 - Br J Obstet Gynaecol. 1988 Nov;95(11):1096-102
11919208 - J Clin Pathol. 2002 Apr;55(4):244-65
9489355 - Minerva Stomatol. 1997 Nov;46(11):595-601
19756360 - Arch Virol. 2009;154(10 ):1609-17
21673418 - Int J Risk Saf Med. 2011;23(2):103-12
10451482 - J Pathol. 1999 Sep;189(1):12-9
26411885 - Vaccine. 2015 Nov 27;33(48):6855-64
21266753 - Jpn J Infect Dis. 2011;64(1):34-9
22777098 - Hum Vaccin Immunother. 2012 Jul;8(7):959
1656586 - Virology. 1991 Nov;185(1):251-7
26501109 - EBioMedicine. 2015 Jul 06;2(9):1114-21
11346722 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):494-6
12167437 - Oral Oncol. 2002 Sep;38(6):591-6
25003090 - Clin Exp Vaccine Res. 2014 Jul;3(2):168-75
17259949 - Clin Pharmacol Ther. 2007 Feb;81(2):259-64
26429676 - Epidemiol Infect. 2016 Feb;144(3):449-68
26239350 - J Clin Med. 2015 Apr 03;4(4):614-33
2157286 - Science. 1990 Apr 6;248(4951):76-9
22342569 - Oral Oncol. 2012 Jul;48(7):578-84
18270337 - J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
26258273 - Curr Opin Oncol. 2015 Sep;27(5):399-404
20022926 - Int J Epidemiol. 2010 Feb;39(1):166-81
26107345 - Pediatr Infect Dis J. 2015 Sep;34(9):983-91
1772858 - Br J Oral Maxillofac Surg. 1991 Dec;29(6):381-7
19135222 - Virology. 2009 Feb 20;384(2):260-5
10874669 - Mod Pathol. 2000 Jun;13(6):644-53
15183049 - Virology. 2004 Jun 20;324(1):17-27
17332919 - Int J Oncol. 2007 Apr;30(4):813-23
24392564 - J Pak Med Assoc. 2013 Oct;63(10):1295-8
15734974 - Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
18154571 - J Oral Pathol Med. 2008 Jan;37(1):1-10
18367526 - J Virol. 2008 Jun;82(11):5190-7
1663794 - Biophys J. 1991 Dec;60(6):1445-56
183728 - Bibl Haematol. 1975 Oct;(43):569-71
9542660 - Int J Dermatol. 1998 Feb;37(2):81-95
18606525 - Int J Oral Maxillofac Surg. 2008 Sep;37(9):840-6
25353286 - Am J Surg Pathol. 2015 Apr;39(4):496-504
1335790 - Semin Cancer Biol. 1992 Oct;3(5):263-71
22018560 - J Adolesc Health. 2011 Nov;49(5):467-75
21617204 - Anticancer Res. 2011 May;31(5):1515-9
20553531 - APMIS. 2010 Jun;118(6-7):510-9
19853182 - Arch Med Res. 2009 Aug;40(6):428-34
26438574 - J Natl Cancer Inst. 2015 Oct 04;108(1):null
12044010 - Nat Rev Cancer. 2002 May;2(5):342-50
2160477 - J Clin Pathol. 1990 Apr;43(4):269-76
21768696 - J Cancer Res Ther. 2011 Apr-Jun;7(2):120-7
22131115 - Acta Dermatovenerol Alp Pannonica Adriat. 2011 Sep;20(3):145-54
10638450 - Int J Gynecol Pathol. 2000 Jan;19(1):16-28
References_xml – volume: 384
  start-page: 260
  year: 2009
  ident: 10.5125/jkaoms.2016.42.6.327_ref49
  publication-title: Virology
  doi: 10.1016/j.virol.2008.11.046
– volume: 19
  start-page: 16
  year: 2000
  ident: 10.5125/jkaoms.2016.42.6.327_ref15
  publication-title: Int J Gynecol Pathol
  doi: 10.1097/00004347-200001000-00004
– volume: 6
  start-page: 723
  year: 2007
  ident: 10.5125/jkaoms.2016.42.6.327_ref57
  publication-title: Expert Rev Vaccines
  doi: 10.1586/14760584.6.5.723
– volume: 43
  start-page: 269
  year: 1990
  ident: 10.5125/jkaoms.2016.42.6.327_ref72
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.43.4.269
– volume: 6
  start-page: 15
  year: 2010
  ident: 10.5125/jkaoms.2016.42.6.327_ref43
  publication-title: Head Face Med
  doi: 10.1186/1746-160X-6-15
– ident: 10.5125/jkaoms.2016.42.6.327_ref53
– volume: 38
  start-page: 20
  year: 2012
  ident: 10.5125/jkaoms.2016.42.6.327_ref1
  publication-title: J Korean Assoc Oral Maxillofac Surg
  doi: 10.5125/jkaoms.2012.38.1.20
– volume: 46
  start-page: 595
  year: 1997
  ident: 10.5125/jkaoms.2016.42.6.327_ref25
  publication-title: Minerva Stomatol
– volume: 100
  start-page: 407
  year: 2008
  ident: 10.5125/jkaoms.2016.42.6.327_ref35
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djn025
– volume: 348
  start-page: 518
  year: 2003
  ident: 10.5125/jkaoms.2016.42.6.327_ref6
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa021641
– volume: 49
  start-page: 179
  year: 2000
  ident: 10.5125/jkaoms.2016.42.6.327_ref19
  publication-title: Minerva Stomatol
– volume: 81
  start-page: 259
  year: 2007
  ident: 10.5125/jkaoms.2016.42.6.327_ref62
  publication-title: Clin Pharmacol Ther
  doi: 10.1038/sj.clpt.6100055
– volume: 185
  start-page: 251
  year: 1991
  ident: 10.5125/jkaoms.2016.42.6.327_ref47
  publication-title: Virology
  doi: 10.1016/0042-6822(91)90772-4
– volume: 82
  start-page: 5190
  year: 2008
  ident: 10.5125/jkaoms.2016.42.6.327_ref8
  publication-title: J Virol
  doi: 10.1128/JVI.02726-07
– volume: 55
  start-page: 244
  year: 2002
  ident: 10.5125/jkaoms.2016.42.6.327_ref5
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.55.4.244
– volume: 154
  start-page: 1609
  year: 2009
  ident: 10.5125/jkaoms.2016.42.6.327_ref69
  publication-title: Arch Virol
  doi: 10.1007/s00705-009-0484-8
– volume: 14
  start-page: 467
  year: 2005
  ident: 10.5125/jkaoms.2016.42.6.327_ref16
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-04-0551
– volume: 6
  start-page: 555
  year: 2014
  ident: 10.5125/jkaoms.2016.42.6.327_ref27
  publication-title: J Adv Prosthodont
  doi: 10.4047/jap.2014.6.6.555
– volume: 324
  start-page: 17
  year: 2004
  ident: 10.5125/jkaoms.2016.42.6.327_ref7
  publication-title: Virology
  doi: 10.1016/j.virol.2004.03.033
– volume: 63
  start-page: 1295
  year: 2013
  ident: 10.5125/jkaoms.2016.42.6.327_ref77
  publication-title: J Pak Med Assoc
– volume: 3
  start-page: 263
  year: 1992
  ident: 10.5125/jkaoms.2016.42.6.327_ref22
  publication-title: Semin Cancer Biol
– volume: 33
  start-page: 6855
  year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref65
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.08.059
– volume: 8
  start-page: 959
  year: 2012
  ident: 10.5125/jkaoms.2016.42.6.327_ref74
  publication-title: Hum Vaccin Immunother
  doi: 10.4161/hv.20043
– volume: 37
  start-page: 1
  year: 2008
  ident: 10.5125/jkaoms.2016.42.6.327_ref39
  publication-title: J Oral Pathol Med
  doi: 10.1111/j.1600-0714.2007.00579.x
– volume: 49
  start-page: 467
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref60
  publication-title: J Adolesc Health
  doi: 10.1016/j.jadohealth.2011.07.003
– volume: 37
  start-page: 81
  year: 1998
  ident: 10.5125/jkaoms.2016.42.6.327_ref71
  publication-title: Int J Dermatol
  doi: 10.1046/j.1365-4362.1998.00435.x
– volume: 39
  start-page: 496
  year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref4
  publication-title: Am J Surg Pathol
  doi: 10.1097/PAS.0000000000000342
– volume: 23
  start-page: 103
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref66
  publication-title: Int J Risk Saf Med
  doi: 10.3233/JRS-2011-0529
– year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref68
  publication-title: J Natl Cancer Inst
– start-page: 278
  volume-title: IARC monographs on the evaluation of carcinogenic risks to humans: IARC monographs, volume 100B. A review of human carcinogens. B. Biological agents
  year: 2012
  ident: 10.5125/jkaoms.2016.42.6.327_ref28
– volume: 186
  start-page: 217
  year: 1994
  ident: 10.5125/jkaoms.2016.42.6.327_ref73
  publication-title: Curr Top Microbiol Immunol
– volume: 64
  start-page: 34
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref76
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.64.34
– volume: 3
  start-page: 168
  year: 2014
  ident: 10.5125/jkaoms.2016.42.6.327_ref33
  publication-title: Clin Exp Vaccine Res
  doi: 10.7774/cevr.2014.3.2.168
– volume: 37
  start-page: 840
  year: 2008
  ident: 10.5125/jkaoms.2016.42.6.327_ref41
  publication-title: Int J Oral Maxillofac Surg
  doi: 10.1016/j.ijom.2008.05.015
– volume: 7
  start-page: 339
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref70
  publication-title: Hum Vaccin
  doi: 10.4161/hv.7.3.14263
– volume: 8
  start-page: 4099
  year: 1989
  ident: 10.5125/jkaoms.2016.42.6.327_ref23
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1989.tb08594.x
– volume: 30
  start-page: F139
  issue: Suppl 5
  year: 2012
  ident: 10.5125/jkaoms.2016.42.6.327_ref44
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2012.05.039
– volume: 2
  start-page: 1114
  year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref56
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2015.07.003
– volume: 7
  start-page: 120
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref50
  publication-title: J Cancer Res Ther
  doi: 10.4103/0973-1482.82915
– volume: 17
  start-page: 394
  year: 2010
  ident: 10.5125/jkaoms.2016.42.6.327_ref34
  publication-title: Adv Anat Pathol
  doi: 10.1097/PAP.0b013e3181f895c1
– ident: 10.5125/jkaoms.2016.42.6.327_ref59
– volume: 302
  start-page: 750
  year: 2009
  ident: 10.5125/jkaoms.2016.42.6.327_ref64
  publication-title: JAMA
  doi: 10.1001/jama.2009.1201
– volume: 40
  start-page: 428
  year: 2009
  ident: 10.5125/jkaoms.2016.42.6.327_ref11
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2009.06.001
– volume: 73
  start-page: 348
  year: 2009
  ident: 10.5125/jkaoms.2016.42.6.327_ref14
  publication-title: Microbiol Mol Biol Rev
  doi: 10.1128/MMBR.00033-08
– volume: 91
  start-page: 494
  year: 2001
  ident: 10.5125/jkaoms.2016.42.6.327_ref26
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  doi: 10.1067/moe.2001.115128
– volume: 13
  start-page: 644
  year: 2000
  ident: 10.5125/jkaoms.2016.42.6.327_ref31
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.3880113
– volume: 20
  start-page: 145
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref12
  publication-title: Acta Dermatovenerol Alp Pannonica Adriat
– volume: 60
  start-page: 1445
  year: 1991
  ident: 10.5125/jkaoms.2016.42.6.327_ref48
  publication-title: Biophys J
  doi: 10.1016/S0006-3495(91)82181-6
– volume: 248
  start-page: 76
  year: 1990
  ident: 10.5125/jkaoms.2016.42.6.327_ref24
  publication-title: Science
  doi: 10.1126/science.2157286
– volume: 2
  start-page: 15
  year: 2010
  ident: 10.5125/jkaoms.2016.42.6.327_ref30
  publication-title: Head Neck Oncol
  doi: 10.1186/1758-3284-2-15
– volume: 56
  start-page: 253
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref40
  publication-title: Aust Dent J
  doi: 10.1111/j.1834-7819.2011.01337.x
– volume: 34
  start-page: 983
  year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref63
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000000793
– volume: 144
  start-page: 449
  year: 2016
  ident: 10.5125/jkaoms.2016.42.6.327_ref45
  publication-title: Epidemiol Infect
  doi: 10.1017/S0950268815002198
– volume: 365
  start-page: 1576
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref55
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1010971
– volume: 4
  start-page: 614
  year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref58
  publication-title: J Clin Med
  doi: 10.3390/jcm4040614
– volume: 27
  start-page: 399
  year: 2015
  ident: 10.5125/jkaoms.2016.42.6.327_ref67
  publication-title: Curr Opin Oncol
  doi: 10.1097/CCO.0000000000000211
– volume: 95
  start-page: 1096
  year: 1988
  ident: 10.5125/jkaoms.2016.42.6.327_ref21
  publication-title: Br J Obstet Gynaecol
  doi: 10.1111/j.1471-0528.1988.tb06785.x
– ident: 10.5125/jkaoms.2016.42.6.327_ref54
– volume: 6
  start-page: S3
  issue: Suppl 1
  year: 2012
  ident: 10.5125/jkaoms.2016.42.6.327_ref10
  publication-title: Head Neck Pathol
  doi: 10.1007/s12105-012-0367-2
– volume-title: Cancer incidence in five continents Vol. X
  year: 2014
  ident: 10.5125/jkaoms.2016.42.6.327_ref2
– volume: 321
  start-page: 59
  year: 2008
  ident: 10.5125/jkaoms.2016.42.6.327_ref13
  publication-title: Curr Top Microbiol Immunol
– volume: 189
  start-page: 12
  year: 1999
  ident: 10.5125/jkaoms.2016.42.6.327_ref3
  publication-title: J Pathol
  doi: 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
– volume: 2
  start-page: 342
  year: 2002
  ident: 10.5125/jkaoms.2016.42.6.327_ref9
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc798
– volume: 39
  start-page: 166
  year: 2010
  ident: 10.5125/jkaoms.2016.42.6.327_ref36
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyp350
– volume: 31
  start-page: 1515
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref75
  publication-title: Anticancer Res
– volume: 100
  start-page: 261
  year: 2008
  ident: 10.5125/jkaoms.2016.42.6.327_ref29
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djn011
– volume: 118
  start-page: 510
  year: 2010
  ident: 10.5125/jkaoms.2016.42.6.327_ref37
  publication-title: APMIS
  doi: 10.1111/j.1600-0463.2010.02624.x
– start-page: 569
  issue: 43
  year: 1975
  ident: 10.5125/jkaoms.2016.42.6.327_ref46
  publication-title: Bibl Haematol
– volume: 30
  start-page: 813
  year: 2007
  ident: 10.5125/jkaoms.2016.42.6.327_ref18
  publication-title: Int J Oncol
– volume: 91
  start-page: 622
  year: 2001
  ident: 10.5125/jkaoms.2016.42.6.327_ref20
  publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  doi: 10.1067/moe.2001.115392
– volume: 29
  start-page: 381
  year: 1991
  ident: 10.5125/jkaoms.2016.42.6.327_ref52
  publication-title: Br J Oral Maxillofac Surg
  doi: 10.1016/0266-4356(91)90006-Q
– volume: 62
  start-page: 870
  year: 2009
  ident: 10.5125/jkaoms.2016.42.6.327_ref17
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.2008.063149
– volume: 48
  start-page: 578
  year: 2012
  ident: 10.5125/jkaoms.2016.42.6.327_ref38
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2012.01.017
– volume: 11
  start-page: 9
  year: 2011
  ident: 10.5125/jkaoms.2016.42.6.327_ref42
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2982
– volume: 21
  start-page: 147
  year: 1983
  ident: 10.5125/jkaoms.2016.42.6.327_ref51
  publication-title: Br J Oral Surg
  doi: 10.1016/0007-117X(83)90060-4
– volume: 38
  start-page: 591
  year: 2002
  ident: 10.5125/jkaoms.2016.42.6.327_ref32
  publication-title: Oral Oncol
  doi: 10.1016/S1368-8375(01)00112-9
– volume: 98
  start-page: 433
  year: 2006
  ident: 10.5125/jkaoms.2016.42.6.327_ref61
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djj144
– reference: 26438574 - J Natl Cancer Inst. 2015 Oct 04;108(1):null
– reference: 11040544 - Minerva Stomatol. 2000 Apr;49(4):179-86
– reference: 19756360 - Arch Virol. 2009;154(10 ):1609-17
– reference: 10874669 - Mod Pathol. 2000 Jun;13(6):644-53
– reference: 15183049 - Virology. 2004 Jun 20;324(1):17-27
– reference: 20633288 - Head Face Med. 2010 Jul 15;6:15
– reference: 26107345 - Pediatr Infect Dis J. 2015 Sep;34(9):983-91
– reference: 26429676 - Epidemiol Infect. 2016 Feb;144(3):449-68
– reference: 25558348 - J Adv Prosthodont. 2014 Dec;6(6):555-8
– reference: 19853182 - Arch Med Res. 2009 Aug;40(6):428-34
– reference: 2849985 - Br J Obstet Gynaecol. 1988 Nov;95(11):1096-102
– reference: 11346722 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 May;91(5):494-6
– reference: 1656586 - Virology. 1991 Nov;185(1):251-7
– reference: 22029979 - N Engl J Med. 2011 Oct 27;365(17):1576-85
– reference: 18334711 - J Natl Cancer Inst. 2008 Mar 19;100(6):407-20
– reference: 10638450 - Int J Gynecol Pathol. 2000 Jan;19(1):16-28
– reference: 16595773 - J Natl Cancer Inst. 2006 Apr 5;98(7):433
– reference: 8205843 - Curr Top Microbiol Immunol. 1994;186:217-53
– reference: 20022926 - Int J Epidemiol. 2010 Feb;39(1):166-81
– reference: 9542660 - Int J Dermatol. 1998 Feb;37(2):81-95
– reference: 19706632 - J Clin Pathol. 2009 Oct;62(10):870-8
– reference: 1335790 - Semin Cancer Biol. 1992 Oct;3(5):263-71
– reference: 22018560 - J Adolesc Health. 2011 Nov;49(5):467-75
– reference: 18606525 - Int J Oral Maxillofac Surg. 2008 Sep;37(9):840-6
– reference: 15734974 - Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
– reference: 1772858 - Br J Oral Maxillofac Surg. 1991 Dec;29(6):381-7
– reference: 9489355 - Minerva Stomatol. 1997 Nov;46(11):595-601
– reference: 21673418 - Int J Risk Saf Med. 2011;23(2):103-12
– reference: 18367526 - J Virol. 2008 Jun;82(11):5190-7
– reference: 17931153 - Expert Rev Vaccines. 2007 Oct;6(5):723-39
– reference: 22782219 - Head Neck Pathol. 2012 Jul;6 Suppl 1:S3-15
– reference: 21266753 - Jpn J Infect Dis. 2011;64(1):34-9
– reference: 18727487 - Curr Top Microbiol Immunol. 2008;321:59-83
– reference: 19135222 - Virology. 2009 Feb 20;384(2):260-5
– reference: 22777098 - Hum Vaccin Immunother. 2012 Jul;8(7):959
– reference: 10451482 - J Pathol. 1999 Sep;189(1):12-9
– reference: 12571259 - N Engl J Med. 2003 Feb 6;348(6):518-27
– reference: 19690307 - JAMA. 2009 Aug 19;302(7):750-7
– reference: 6307342 - Br J Oral Surg. 1983 Jun;21(2):147-53
– reference: 21617204 - Anticancer Res. 2011 May;31(5):1515-9
– reference: 11919208 - J Clin Pathol. 2002 Apr;55(4):244-65
– reference: 21160525 - Nat Rev Cancer. 2011 Jan;11(1):9-22
– reference: 18154571 - J Oral Pathol Med. 2008 Jan;37(1):1-10
– reference: 12044010 - Nat Rev Cancer. 2002 May;2(5):342-50
– reference: 24392564 - J Pak Med Assoc. 2013 Oct;63(10):1295-8
– reference: 21884139 - Aust Dent J. 2011 Sep;56(3):253-6
– reference: 12167437 - Oral Oncol. 2002 Sep;38(6):591-6
– reference: 25003090 - Clin Exp Vaccine Res. 2014 Jul;3(2):168-75
– reference: 21358269 - Hum Vaccin. 2011 Mar;7(3):339-48
– reference: 26258273 - Curr Opin Oncol. 2015 Sep;27(5):399-404
– reference: 2157286 - Science. 1990 Apr 6;248(4951):76-9
– reference: 26501109 - EBioMedicine. 2015 Jul 06;2(9):1114-21
– reference: 17259949 - Clin Pharmacol Ther. 2007 Feb;81(2):259-64
– reference: 26239350 - J Clin Med. 2015 Apr 03;4(4):614-33
– reference: 2556261 - EMBO J. 1989 Dec 20;8(13):4099-105
– reference: 18270337 - J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
– reference: 17332919 - Int J Oncol. 2007 Apr;30(4):813-23
– reference: 11402272 - Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):622-35
– reference: 183728 - Bibl Haematol. 1975 Oct;(43):569-71
– reference: 26411885 - Vaccine. 2015 Nov 27;33(48):6855-64
– reference: 2160477 - J Clin Pathol. 1990 Apr;43(4):269-76
– reference: 20553531 - APMIS. 2010 Jun;118(6-7):510-9
– reference: 23199957 - Vaccine. 2012 Nov 20;30 Suppl 5:F139-48
– reference: 19487731 - Microbiol Mol Biol Rev. 2009 Jun;73(2):348-70
– reference: 22131115 - Acta Dermatovenerol Alp Pannonica Adriat. 2011 Sep;20(3):145-54
– reference: 1663794 - Biophys J. 1991 Dec;60(6):1445-56
– reference: 20587061 - Head Neck Oncol. 2010 Jun 29;2:15
– reference: 20966645 - Adv Anat Pathol. 2010 Nov;17(6):394-403
– reference: 25353286 - Am J Surg Pathol. 2015 Apr;39(4):496-504
– reference: 22342569 - Oral Oncol. 2012 Jul;48(7):578-84
– reference: 21768696 - J Cancer Res Ther. 2011 Apr-Jun;7(2):120-7
SSID ssj0000627372
Score 2.2889771
SecondaryResourceType review_article
Snippet Cervical cancer is the second most prevalent cancer among women, and it arises from cells that originate in the cervix uteri. Among several causes of cervical...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 327
SubjectTerms Review
치의학
Title Human papilloma virus in oral cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/28053902
https://www.proquest.com/docview/1855790751
https://pubmed.ncbi.nlm.nih.gov/PMC5206237
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002175093
Volume 42
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 대한구강악안면외과학회지, 2016, 42(6), , pp.327-336
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB71cekFgSglBapQ9ZqQdRzbOSGEqApSOXWl3iy_AmG3yTa7i-DfM5NkVywqglMOdmL7G4_nG8eeAbjwEm1CQE81yCATbjKfKIFELqCwvWFWVf2G_vVncTXln26L2z3Y5GwdAVw-6NpRPqlpN09_3P98iwqP_DVFc1W8-TYz7R2F3p6IlLNUpDmT-3CItkmSql6PhH9YmxnlZaGMcyzniUR-Ptyn--uHduzVftNVD1HRP09U_maiLh_Do5Fbxu-GyfAE9kLzFC76bfp4YRb1fN7emfh73a2Xcd3EdDc_diT17himlx9u3l8lY2qExGH3V0lQIni0xCIoX1pZuYrJzJTWSTuphHIeeVtVUqwwn3vu8iCVy2Q5ccoJW_AqfwYHTduE5xCrAj0uYQOWBo4ab3DZybg1Kq9sYaWPIN8AoN0YN5zSV8w1-g8Emx5g0wSb5kwLjbBFkGzfWgxxM_5R_xyx1TNXawp4Tc8vrZ51Gmn9R02kBLliBK830GvUAvq1YZrQrpcaWUch0c8vJhGcDKLYNssULjRlxiKQO0LaVqAGd0ua-msfabtgOGFyefo_nXsBRzSi4ajLSzhYdevwCgnLyp71c_Cs30n6BenD59c
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+papilloma+virus+in+oral+cancer&rft.jtitle=Journal+of+the+Korean+Association+of+Oral+and+Maxillofacial+Surgeons&rft.au=%EA%B9%80%EC%84%B1%EB%AF%BC&rft.date=2016-12-01&rft.pub=%EB%8C%80%ED%95%9C%EA%B5%AC%EA%B0%95%EC%95%85%EC%95%88%EB%A9%B4%EC%99%B8%EA%B3%BC%ED%95%99%ED%9A%8C&rft.issn=2234-7550&rft.eissn=2234-5930&rft.spage=327&rft.epage=336&rft_id=info:doi/10.5125%2Fjkaoms.2016.42.6.327&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_1293083
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-7550&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-7550&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-7550&client=summon